Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Current Availability and Guidance in the UK Retatrutide is not licensed by the MHRA and is unavailable outside clinical trials in the UK
Safety information The most common side effects include nausea, vomiting, diarrhea, and abdominal pain
These patents apply to both Ozempic (approved for type 2 diabetes) and Wegovy (approved for chronic weight management)
Thus, among women randomized to the highest retatrutide dose, percentage mean weight loss at 48 weeks was 28.5% versus 21.9% among men
US$ 21.91
US$ 20.86
US$ 23.29
